Ipca Lab gains despite reporting 53% plunge in Q2FY15 net profit

11 Nov 2014 Evaluate

Ipca Laboratories is currently trading at Rs. 658.90, up by 21.65 points or 3.40% from its previous closing of Rs. 637.25 on the BSE.

The scrip opened at Rs. 639.00 and has touched a high and low of Rs. 660.00 and Rs. 630.00 respectively. So far 68846 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 906.90 on 28-Feb-2014 and a 52 week low of Rs. 630.00 on 10-Nov-2014.

Last one week high and low of the scrip stood at Rs. 728.00 and Rs. 630.00 respectively. The current market cap of the company is Rs. 8247.74 crore.

The promoters holding in the company stood at 45.89 % while Institutions and Non-Institutions held 35.82 % and 18.28 % respectively.

Ipca Laboratories has registered 52.65% fall in its net profit at Rs 61.30 crore for second quarter ended September 30, 2014 as compared to Rs 129.45 crore for the same quarter in the previous year. Total income of the company has decreased 7.36% at Rs 789.31 crore for Q2FY15 as compared Rs 852.03 crore for the corresponding quarter previous year.

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.

Ipca Laboratories Share Price

1299.55 15.55 (1.21%)
17-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5802.00
Cipla 1399.35
Zydus Lifesciences 1051.90
Lupin 1653.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.